Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

Checkmate Pharmaceuticals, Inc. (CMPI) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/10/2022 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
06/07/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
06/07/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
06/03/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
06/03/2022 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
06/02/2022 EFFECT Form EFFECT - Notice of Effectiveness:
05/31/2022 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
05/31/2022 4 POWELL MICHAEL (Director) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.
Txns: Disposed/sold 30,000 options to buy @ $5.19, valued at $155.7k
Disposed/sold 10,030 options to buy @ $6.27, valued at $62.9k
Disposed/sold 30,000 options to buy @ $10.95, valued at $328.5k
05/31/2022 4 Flaherty Keith T. (Director) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.
Txns: Disposed/sold 10,030 options to buy @ $6.27, valued at $62.9k
Disposed/sold 4,012 options to buy @ $2.47, valued at $9.9k
Disposed/sold 22,736 options to buy @ $2.62, valued at $59.6k
05/31/2022 4 Isacoff Oren (Director) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.
Txns: Disposed/sold 10,030 options to buy @ $6.27, valued at $62.9k
Disposed/sold 20,000 options to buy @ $10.95, valued at $219k
05/31/2022 4 Colabuono Peter (Director) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.
Txns: Disposed/sold 10,030 options to buy @ $6.27, valued at $62.9k
Disposed/sold 20,000 options to buy @ $10.95, valued at $219k
05/31/2022 4 Yan Joy (Director) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.
Txns: Disposed/sold 20,061 options to buy @ $3.12, valued at $62.6k
05/31/2022 4 Dolski Robert (CFO) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.
Txns: Disposed/sold 101,180 options to buy @ $2.05, valued at $207.4k
Disposed/sold 27,300 options to buy @ $5.09, valued at $139k
Disposed/sold 150,000 options to buy @ $14.84, valued at $2.2M
05/31/2022 4 Wooldridge James (Chief Medical Officer) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.
Txns: Disposed/sold 54,600 options to buy @ $13.5, valued at $737.1k
Disposed/sold 101,180 options to buy @ $2.05, valued at $207.4k
Disposed/sold 27,300 options to buy @ $5.09, valued at $139k
Disposed/sold 150,818 options to buy @ $15, valued at $2.3M
Disposed/sold 95,916 options to buy @ $2.62, valued at $251.3k
05/31/2022 4 Wigginton Jon Marc (Director) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.
Txns: Disposed/sold 20,061 options to buy @ $2.19, valued at $43.9k
05/31/2022 4 Fuhrman Alan (Director) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.
Txns: Disposed/sold 246,671 options to buy @ $3.93, valued at $969.4k
Disposed/sold 10,030 options to buy @ $6.27, valued at $62.9k
Disposed/sold 22,736 options to buy @ $2.62, valued at $59.6k
05/31/2022 4 BASH ALAN (CEO) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.
Txns: Disposed/sold 575,000 options to buy @ $2.99, valued at $1.7M
05/31/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/31/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/31/2022 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/31/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
05/31/2022 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs: "FIFTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF",
"CHECKMATE PHARMACEUTICALS, INC."
05/31/2022 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
05/31/2022 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
05/20/2022 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
05/20/2022 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
05/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/12/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/12/2022 8-K Quarterly results
05/11/2022 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
05/11/2022 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
05/11/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
05/09/2022 4 venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 4 on Checkmate Pharmaceuticals, Inc.
Txns: Sold 20,743 shares @ $10.37, valued at $215.1k
Sold 48,334 shares @ $10.3702, valued at $501.2k
Sold 17,600 shares @ $10.374, valued at $182.6k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy